Spyre Therapeutics announces a $350 million stock offering, leading to a 12% drop in shares to $81.83.

Observed price moves

• SYRE-5.74%10 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.